Results for somministrat translation from Maltese to English

il-prodott m’ghandux jigi somministrat qabel ir-rikostitwizzjoni.
the unreconstituted contents of the vial before radiolabelling are not to be directly administered to patients.

dan il-prodott jista jigi uzat u somministrat biss minn persuni awtorizzati f’strutturi dedikati.
this radiopharmaceutical may be received, used and administered only by authorised persons in designated clinical settings.

150 mg ġurnata iva u ġurnata 3 darbiet fil - ġimgħa) huwa irrikmandat meta somministrat ma kaletra.
150 mg every other day or 3 times per week) is recommended when administered with kaletra.

dilwizzjoni mingħand il-professjonist tal-kura tas-saħħa għanda sseħħ qabel ma jiġi somministrat.
further dilution by a healthcare provider is required prior to administration.

150 mg ġurnata iva u ġurnata 3 darbiet fil - ġimgħa) huwa irrikmandat meta somministrat ma ’ kaletra.
kaletra was demonstrated to lower plasma concentrations of methadone.

- kaletra m’ ghandux jigi somministrat lit- tfal ta ’ taħt is- sentejn sakemm mhux speċifikament
each film-coated tablet contains 200 mg of lopinavir co-formulated with 50 mg of ritonavir as a pharmacokinetic enhancer.

kaletra jista ’ jiġi ko- somministrat ma ’ buprenorphine mingħajr bżonn ta ’ aġġustament fid- doża.
voriconazole: due to the potential for reduced voriconazole concentrations, co-administration of voriconazole and low dose ritonavir (100 mg twice daily) as contained in kaletra should be avoided unless an assessment of the benefit/ risk to patient justifies the use of voriconazole.

il-prodott mediku għandu jkun somministrat għall-anqas permezz tar-rotta rrikkmandata ta' amministrazzjoni.
the medicinal product shall be administered at least via the recommended route of administration.

huwa aċċettat li l-kontroll pożittiv jiġi somministrat minn rotta differenti minn dik tas-sustanza tat-test u jittieħed kampjun darba waħda biss.
it is acceptable that the positive control be administered by a route different from the test substance and sampled at only a single time.

il-prodott għandu jkun somministrat fir-razzjon ta' kuljum f'għall-inqas żewġ livelli ta' inkorporazzjoni.
the product should be admininstered in the daily ration in at least two levels ofincorporation.

prodott mediċinali veterinarju immunoloġiku: prodott mediċinali veterinarju somministrat lill-annimali biex joħloq immunità attiva jew passiva jew biex ikun iddijanjożat l-istat ta' immunità.
immunological veterinary medicinal product: a veterinary medicinal product administered to animals in order to produce active or passive immunity or to diagnose the state of immunity.

in ġenerali, dawn l-istudji għandhom isiru fuq żewġ speċi ta' annimali, li wieħed minnhom ikun annimal gerriemi. il-prodott għandu jiġi somministrat fir-razzjon ta' kuljum għall-inqas f'żewġ livelli ta' inkorporazzjoni.
in general, these studies should be carried out on two animal species, one of which being a rodent.the product should be administered in the daily ration in at least two levels of incorporation.